Vitrafy Life Sciences Limited (ASX:VFY)
3.810
+0.010 (0.26%)
Aug 26, 2026, 3:58 PM AEST
Vitrafy Life Sciences Company Description
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia.
It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device.
Its cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs.
Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Vitrafy Life Sciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | Software - Infrastructure |
| Sector | Technology |
| CEO | Brenton Michael Owens |
Contact Details
Address: 385 Bourke Street Melbourne, VIC 3000 Australia | |
| Phone | 61 3 9692 7222 |
| Website | vitrafy.com |
Stock Details
| Ticker Symbol | VFY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000361297 |
| SIC Code | 3821 |
Key Executives
| Name | Position |
|---|---|
| Brenton Michael Leslie Owens | Co-Founder, MD, Chief Executive Officer and Executive Director |
| Simon Thomas Martin | Chief Financial Officer |